AdaptHealth Corp. financials

AHCO CIK 0001725255

Source: EDGAR filings · Built 2026-06-02T02:16:25Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 200.91M 225.92M 136.43M -33.73M 30.21M 116.83M
EBITDA 472.80M 629.07M -215.62M 541.59M 483.66M 153.79M
Working Capital 16.51M 188.80M 112.02M 129.09M 170.25M -58.80M
Net Debt 1.80B 2.02B 2.22B 2.28B 2.22B 712.64M
Gross Margin 18.77% 20.89% 19.50% 19.53% 18.15% 14.94%
Operating Margin 2.80% 8.09% -18.70% 6.41% 9.19% 6.75%
Net Margin -2.18% 2.77% -21.21% 2.33% 6.36% -15.30%
Return on Equity (ROE) -4.66% 5.76% -46.55% 3.22% 7.57% -45.54%
Return on Assets (ROA) -1.64% 2.02% -15.06% 1.33% 2.97% -8.91%
Current Ratio 1.02× 1.33× 1.21× 1.28× 1.34× 0.86×
Debt-to-Equity 1.25× 1.36× 1.57× 1.08× 1.15× 2.27×
Effective Tax Rate -335.78% 30.32% 6.77% 25.30% 17.18% 5.80%
Cash Conversion Ratio -8.50× 5.99× -0.71× 5.39× 1.77× -1.21×
Accruals Ratio -0.16× -0.10× -0.26× -0.06× -0.02× -0.20×
SBC % of Revenue 0.67% 0.46% 0.70% 0.75% 1.03% 1.77%
CapEx Coverage 1.50× 1.72× 1.40× 0.92× 1.12× 2.48×
Free Cash Flow Per Share $1.49 $1.67 $1.01 $-0.24 $0.23 $2.23

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 15.61× 58.24× 36.51×
P/FCF 6.70× 5.71× 7.18× 107.71× 16.87×
FCF Yield 14.93% 17.51% 13.92% 0.93% 5.93%
EV / EBITDA 6.65× 5.25× 8.99× 11.36× 17.45×
P/S 0.42× 0.39× 0.30× 0.87× 1.33× 1.87×
P/B 0.89× 0.82× 0.66× 1.20× 1.59× 5.56×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 3.24B 3.26B 3.20B 2.97B 2.45B 1.06B
Cost of Goods and Services Sold 2.64B 2.58B 2.58B 2.39B 2.01B 898.60M
Cost of Revenue 2.64B 2.58B 2.58B 2.39B 2.01B 898.60M
Operating Income (Loss) 90.87M 263.73M -598.40M 190.41M 225.60M 71.35M
Income Tax Expense (Benefit) 50.88M 41.24M -49.00M 24.77M 32.81M -11.96M
Net Income (Loss) Attributable to Parent -70.79M 90.42M -678.89M 69.32M 156.18M -161.63M
Earnings Per Share, Basic $-0.52 $0.62 $-5.06 $0.47 $1.12 $-3.08
Weighted Average Number of Shares Outstanding, Basic 135.15M 133.76M 134.16M 134.18M 126.31M 52.49M
Earnings Per Share, Diluted $-0.52 $0.61 $-5.31 $0.33 $0.67 $-3.08
Weighted Average Number of Shares Outstanding, Diluted 135.15M 135.53M 134.42M 138.99M 133.03M 52.49M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Assets, Current 728.90M 755.79M 649.02M 585.31M 670.06M 363.25M
Assets 4.32B 4.49B 4.51B 5.22B 5.25B 1.81B
Long-term Debt 1.74B 1.98B 2.15B 2.19B 2.20B 784.71M
Liabilities, Current 712.39M 566.99M 537.00M 456.21M 499.81M 422.05M
Long-term Debt, Excluding Current Maturities 1.72B 1.96B 2.09B 2.15B 2.18B 776.57M
Liabilities 2.79B 2.91B 3.04B 3.06B 3.18B 1.53B
Stockholders' Equity Attributable to Parent 1.52B 1.57B 1.46B 2.15B 2.06B 354.89M
Common Stock, Shares, Outstanding 135.45M 134.60M 132.63M 134.44M 133.84M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 601.77M 541.84M 480.67M 373.87M 275.68M 195.63M
Payments to Acquire Property, Plant, and Equipment 382.39M 306.06M 337.46M 391.42M 203.31M 39.76M
Net Cash Provided by (Used in) Investing Activities -303.19M -310.27M -357.28M -411.17M -1.82B -815.70M
Payments for Repurchase of Common Stock 0 0 29.27M 13.99M 0 0
Net Cash Provided by (Used in) Financing Activities -302.19M -198.95M -92.53M -66.05M 1.60B 643.15M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AHCO CIK 0001725255), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RVSB

RIVERVIEW BANCORP, INC.

BDTX

BLACK DIAMOND THERAPEUTICS, INC.

IDR

IDAHO STRATEGIC RESOURCES, INC